Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture
- 27 December 2004
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 327 (3), 960-966
- https://doi.org/10.1016/j.bbrc.2004.12.099
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Porcine adenovirus serotype 3 internalization is independent of CAR and αvβ3 or αvβ5 integrinVirology, 2005
- Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in cultureVirus Research, 2004
- Development of adenovirus serotype 35 as a gene transfer vectorVirology, 2003
- Characterization of Bovine Adenovirus Type 3 E1 Proteins and Isolation of E1-Expressing Cell LinesVirology, 2002
- Circumvention of Vector-Specific Neutralizing Antibody Response by Alternating Use of Human and Non-Human Adenoviruses: Implications in Gene TherapyVirology, 2000
- Canine Adenovirus Vectors: an Alternative for Adenovirus-Mediated Gene TransferJournal of Virology, 2000
- Development of porcine adenovirus-3 as an expression vector.Journal of General Virology, 1999
- Systematic Analysis of Repeated Gene Delivery into Animal Lungs with a Recombinant Adenovirus VectorHuman Gene Therapy, 1996
- Development of a bovine adenovirus type 3-based expression vectorJournal of General Virology, 1995
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.Proceedings of the National Academy of Sciences of the United States of America, 1994